Deenen, M. J., Klümpen, H., Richel, D. J., Sparidans, R. W., Weterman, M. J., Beijnen, J. H., . . . Wilmink, J. W. (2011). Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies. Springer US.
Citación estilo ChicagoDeenen, Maarten J., Heinz-Josef Klümpen, Dick J. Richel, Rolf W. Sparidans, Mariette J. Weterman, Jos H. Beijnen, Jan H. M. Schellens, y Johanna W. Wilmink. Phase I and Pharmacokinetic Study of Capecitabine and the Oral MTOR Inhibitor Everolimus in Patients With Advanced Solid Malignancies. Springer US, 2011.
Cita MLADeenen, Maarten J., et al. Phase I and Pharmacokinetic Study of Capecitabine and the Oral MTOR Inhibitor Everolimus in Patients With Advanced Solid Malignancies. Springer US, 2011.